What if AI could help older adults stay healthy and independent—without replacing the human care they still need? In this conversation, Karen Eggleston, PhD. discusses Stanford Health AI Week and shares insights from health systems…
Short sellers usually do not receive much sympathy when stocks are climbing. And when the surge is linked to artificial intelligence, record highs, and a White House keen to take credit for investor gains, they…
Wall Street has spent the first half of 2026 worrying about SpaceX and its Starlink satellite service crashing the wireless party. Shares of T-Mobile are down 10% in 2026 in light of investor concerns about…
Mortgage rates have been hovering around 6.5% for eight weeks, according to Freddie Mac data. It looked like there may be clearer roads ahead the week of July 3, when the 30-year fixed rate decreased.…
Yes, Jim Cramer has said a lot of things about a lot of stocks over the years. But when the “Mad Money” host identifies a single name as the market’s directional signal, that is a…
SpaceX (SPCX) is the most crowded new trade on Wall Street. It was priced at $135 in June, spiked above $225, then settled near $150. The banks that took SpaceX public were barred from publishing…
Semiconductor stocks have dominated every performance leaderboard in 2026, with memory and equipment makers delivering triple-digit gains that dwarf the broader market. Yet the fund capturing most of that upside is not the industry’s largest,…
The U.S. is truly a special, entrepreneurial oasis where anyone can succeed. The fact that one American stock, Nvidia (NVDA), is worth more than the French, German, and Italian stock markets combined says it all. I…
IBM and Red Hat commercially launched Lightwell on July 8, turning a $5 billion pledge into two products that enterprises can actually buy. Most corporate security promises stay abstract for months before a product ships.…
SpaceX (SPCX) stock is trading near $153 on July 9. All the initial gains since its IPO have been wiped out, despite the stock’s inclusion in the Nasdaq-100, and a slew of high price targets…